U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H15NO4
Molecular Weight 297.3053
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of RPI-1

SMILES

COC1=C(OC)C=C2C(NC(=O)\C2=C/C3=CC=C(O)C=C3)=C1

InChI

InChIKey=JGSMCYNBVCGIHC-QPEQYQDCSA-N
InChI=1S/C17H15NO4/c1-21-15-8-12-13(7-10-3-5-11(19)6-4-10)17(20)18-14(12)9-16(15)22-2/h3-9,19H,1-2H3,(H,18,20)/b13-7-

HIDE SMILES / InChI

Molecular Formula C17H15NO4
Molecular Weight 297.3053
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma.
2004 Jul 7
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:13:08 UTC 2023
Edited
by admin
on Sat Dec 16 19:13:08 UTC 2023
Record UNII
LJ66VPR7DB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RPI-1
Code English
1,3-Dihydro-3-[(4-hydroxyphenyl)methylene]-5,6-dimethoxy-2H-indol-2-one
Systematic Name English
RPI1
Code English
2H-Indol-2-one, 1,3-dihydro-3-[(4-hydroxyphenyl)methylene]-5,6-dimethoxy-
Systematic Name English
RPI 1 [WHO-DD]
Common Name English
Code System Code Type Description
CAS
269730-03-2
Created by admin on Sat Dec 16 19:13:08 UTC 2023 , Edited by admin on Sat Dec 16 19:13:08 UTC 2023
PRIMARY
PUBCHEM
1749978
Created by admin on Sat Dec 16 19:13:08 UTC 2023 , Edited by admin on Sat Dec 16 19:13:08 UTC 2023
PRIMARY
FDA UNII
LJ66VPR7DB
Created by admin on Sat Dec 16 19:13:08 UTC 2023 , Edited by admin on Sat Dec 16 19:13:08 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY